$DJI 0.59% NDX 0.99% SPX 0.49% VIX 9.04% News *
Sun, Sep 22 2:02am

VRTX $178.12 1.98 (1.12%)
Vertex Pharmaceuticals Inc | NASDAQ

VRTX Profile

Market Cap 44.50 Billion
VRTX Description

Vertex Pharmaceuticals discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, and Symdeko for cystic fibrosis, in addition to several pipeline candidates targeting this market. Vertex's pipeline also includes therapies for cancer, pain, inflammatory diseases, influenza, and other rare diseases.


Visit Website

VRTX Earnings

EPS 1.04 P/E Ratio 20.79
Previous Tue, Apr 30, 2019
Latest Wed, Jul 31, 2019 (53 days ago) +5.06%

VRTX Dividend

Yield --
Ex-Date --
Pay Date --
History --

VRTX Charts

$151.80
1 Year
$194.78
Dec 24, 2018
Jan 18, 2019



Symbol Price Day Δ YTD Δ
VRTX $178.12 1.12% 8.56%

Advertisers

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy